Population and non-compartmental pharmacokinetic analysis of ripretinib and its active metabolite in Chinese patients with gastrointestinal stromal tumor.

被引：0
|
作者：
Li, Jian [1 ]
Zhang, Jun [2 ]
Wu, Xingye [2 ]
Wu, Chao [2 ]
Dong, Juan [3 ]
Huang, Liang [3 ]
Shen, Lin [1 ]
机构：
[1] Peking Univ, Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[3] Zai Lab Shanghai Co Ltd, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB126
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study
    Kotila, Olayinka A. A.
    Ajayi, David T. T.
    Masimerembwa, Collen
    Thelingwani, Roslyn
    Odetunde, Abayomi
    Falusi, Adeyinka G. G.
    Babalola, Chinedum P. P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (11) : 3454 - 3459
  • [2] Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy
    Yunli Yu
    Quanying Zhang
    Wenjun Xu
    Chengzhe Lv
    Gang Hao
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 345 - 351
  • [3] Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy
    Yu, Yunli
    Zhang, Quanying
    Xu, Wenjun
    Lv, Chengzhe
    Hao, Gang
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (04) : 345 - 351
  • [4] Erratum to: Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy
    Yunli Yu
    Quanying Zhang
    Wenjun Xu
    Chengzhe Lv
    Gang Hao
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 171 - 171
  • [5] COMPARISON OF NON-COMPARTMENTAL ANALYSIS (NCA) ESTIMATION AND POPULATION PHARMACOKINETIC (PPK) PREDICTIONS OF EXPOSURE CHANGES AS A FUNCTION OF RENAL IMPAIRMENT
    Ahmed, M. A.
    Florian, J.
    Madabushi, R.
    Younis, I. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S97 - S97
  • [6] A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.
    Awatsu, Takahito
    Hirano, Hidekazu
    Matsuguma, Kunihito
    Hirose, Toshiharu
    Okita, Natsuko Tsuda
    Shoji, Hirokazu
    Takashima, Atsuo
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 730 - 730
  • [7] Comparative PK evaluation of SHL vs EHL by non-compartmental and compartmental population PK analysis in patients with severe and moderate HA
    Mancuso, Maria Elisa
    Morfini, Massimo
    Iorio, Alfonso
    Arun, Arathi
    Novembrino, Cristina
    Boscolo, Massimo
    Peyvandi, Flora
    Santagostino, Elena
    HAEMOPHILIA, 2020, 26 : 63 - 63
  • [8] Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients
    Chen, Qiong
    Li, Rong
    Zhang, Zhi-Gao
    Deng, Qiao-Ting
    Li, Kun
    Wang, Hao
    Yang, Xue-Xi
    Wu, Ying-Song
    ONCOTARGETS AND THERAPY, 2018, 11 : 2279 - 2286
  • [9] Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients
    Ji, Shuangmin
    Shang, Dewei
    Wu, Kehua
    Li, Anning
    Li, Xiwei
    Deng, Chenhui
    Li, Liang
    Zhou, Tianyan
    Wang, Chuanyue
    Lu, Wei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (05) : 378 - 389
  • [10] Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
    Kim, Jung-Ryul
    Seo, Hyo-Bum
    Cho, Joo-Youn
    Kang, Do-Hyung
    Kim, Yong Ku
    Bahk, Won-Myong
    Yu, Kyung-Sang
    Shin, Sang-Goo
    Kwon, Jun Soo
    Jang, In-Jin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 802 - 810
12345